EU BPR COMPLIANCE SERVICES
The EU Biocidal Products Regulation (EU BPR, Regulation (EU) No 528/2012) governs the placing on the market and use of biocidal active substances, biocidal products and treated articles in the European Union. Disinfectants, preservatives, insecticides, repellents and many antimicrobial, anti-mould or preservative-treated downstream products may fall within its scope.
From a compliance perspective, EU BPR can be understood through three main layers: biocidal active substances, biocidal products and treated articles. Before entering the EU market, companies should first determine the product status, relevant product type (PT) and active substance status, and then assess whether Article 95, technical equivalence, product authorisation, national transitional measures or treated article requirements apply.
REACH24H provides end-to-end EU BPR compliance support, from regulatory scoping and active substance/Article 95 strategy to product authorisation, testing and risk assessment, treated article compliance and post-authorisation maintenance.
Does EU BPR Apply to Your Product?
The first step is not to start a “BPR registration” immediately, but to determine how the product is regulated. Products making similar antimicrobial, anti-mould or disinfectant claims can follow very different compliance routes depending on composition, primary function, claims, use pattern and active substance status.
| Your product / business situation | What to confirm first | Typical compliance route |
|---|---|---|
| You manufacture or supply a biocidal active substance to the EU | Active substance identity, source, PT and approval status | Active substance approval, Article 95 and, where relevant, technical equivalence |
| You manufacture disinfectants, preservatives, insecticides, repellents or other end-use biocidal products | Whether it is a biocidal product, the relevant PT and active substance status | Product authorisation; national transitional requirements where applicable |
| Your product is treated with antimicrobial, anti-mould or preservative purposes | Whether it is a treated article or a product with a primary biocidal function | Treated article compliance; reassess product authorisation if the primary function is biocidal |
| You change the active substance manufacturer, production site or manufacturing process | Whether the new source is equivalent to the approved reference source | Technical equivalence (TE) assessment |
| You plan to sell in one or more EU Member States | Target markets and existing authorisation status | National authorisation, mutual recognition, Union authorisation or another applicable route |
| You are unsure whether BPR applies | Composition, use, target organisms, claims and market plan | BPR scope and route assessment |
Understanding EU BPR
Regulation (EU) No 528/2012 has applied since 1 September 2013 and replaced the former Biocidal Products Directive (Directive 98/8/EC, BPD). The BPR aims to improve the functioning of the EU biocidal products market while ensuring a high level of protection for human and animal health and the environment.
For biocidal products, the core market-access logic follows two consecutive steps:
Active substance level: the active substance is evaluated and, where the criteria are met, approved for a specified product type.
Product level: a biocidal product consisting of, containing or generating the approved active substance(s) is then authorised through the applicable route before it is made available on the market or used.
For active substance/product-type combinations still under the Review Programme, biocidal products may remain subject to national transitional measures while the active substance is under evaluation.
2026 Regulatory Update
ECHA states that the Review Programme is foreseen to be completed by 31 December 2030. Regulation (EU) 2026/1165 also extends the Article 95(5) data-protection periods for certain active substance/product-type combinations until 31 December 2030. Projects relying on the Review Programme, data access or Article 95 strategy should therefore be assessed against the latest active substance status and data-protection position.
What Are the 22 EU BPR Product Types (PTs)?
In Annex V to the EU BPR, biocidal products are classified into 22 product types, grouped into four main groups. The applicable PT is a key factor in determining active substance status, data requirements and the subsequent product authorisation strategy.
| Main Group | Product Types (PTs) |
|---|---|
| Main group 1: Disinfectants | PT 1 Human hygiene PT 2 Disinfectants and algaecides not intended for direct application to humans or animals PT 3 Veterinary hygiene PT 4 Food and feed area PT 5 Drinking water |
| Main group 2: Preservatives | PT 6 Preservatives for products during storage PT 7 Film preservatives PT 8 Wood preservatives PT 9 Fibre, leather, rubber and polymerised materials preservatives PT 10 Construction material preservatives PT 11 Preservatives for liquid-cooling and processing systems PT 12 Slimicides PT 13 Working or cutting fluid preservatives |
| Main group 3: Pest control | PT 14 Rodenticides PT 15 Avicides PT 16 Molluscicides, vermicides and products to control other invertebrates PT 17 Piscicides PT 18 Insecticides, acaricides and products to control other arthropods PT 19 Repellents and attractants PT 20 Control of other vertebrates |
| Main group 4: Other biocidal products | PT 21 Antifouling products PT 22 Embalming and taxidermist fluids |
EU BPR Active Substance Compliance: Approval, Article 95 and Technical Equivalence
1. Active Substance Approval
An active substance is a substance or micro-organism that has an action on or against harmful organisms. At the start of a project, companies should confirm whether the relevant active substance/PT combination is approved, listed in Annex I to the BPR, or still included in the Review Programme.
For a new active substance or a new PT, active substance-level assessment is required. An approval dossier may include substance identity, physicochemical properties, efficacy, human health, ecotoxicology, environmental fate and behaviour, exposure and risk assessment data. The exact data package depends on the substance, PT, existing data and application strategy.
2. Article 95 List of Active Substances and Suppliers
Article 95 is a key supply-chain market-access requirement under the BPR. For a biocidal product, companies should verify that the relevant substance supplier or product supplier is included in the ECHA Article 95 list for the applicable active substance/PT combination.
An Article 95 application may rely on the applicant's own data, a Letter of Access (LoA), or another lawful route to data access. Article 95 should not be confused with the active substance requirements for treated articles; producers or importers of treated articles are not themselves subject to Article 95 merely because an article has been treated.
For non-EU/EEA companies, the appropriate Article 95, supply-chain and authorisation-holder structure should be designed around the company's EU legal entities, importers/customers, data ownership and commercial-control needs.
3. Technical Equivalence (TE)
Where the source of an active substance differs from the approved reference source, or where the manufacturing process or manufacturing location changes, technical equivalence may need to be assessed to determine whether the new source is sufficiently equivalent to the reference source in chemical composition and hazard profile.
Biocidal Product Authorisation: Which EU BPR Market-Access Route Applies?
As a general rule, once the relevant active substance is approved for the applicable PT, the biocidal product must obtain the appropriate authorisation before it can be made available on the market or used.
| Authorisation route | Typical use case |
|---|---|
| National Authorisation | The product is mainly intended for one Member State. |
| Mutual Recognition | The product is already authorised, or being authorised, in one Member State and the company wants access to additional Member States. |
| Union Authorisation | The product meets the applicable conditions and the company seeks broader EU-wide market coverage. |
| Simplified Authorisation | The product meets the specific simplified-authorisation conditions under the BPR, including the relevant Annex I requirements. |
| National Transitional Measures | The relevant existing active substance remains in the Review Programme and the target Member State allows the product to be marketed under national transitional measures. |
Depending on the product portfolio, companies may also assess options such as same biocidal product authorisation or a biocidal product family strategy. ECHA's product authorisation guidance provides the official framework for national authorisation and mutual recognition.
Treated Articles: Compliance for Antimicrobial, Anti-Mould and Preservative-Treated Products
A treated article is any substance, mixture or article that has been treated with, or intentionally incorporates, one or more biocidal products. Typical examples include antimicrobial or preservative-treated textiles, clothing, leather, plastics, rubber, wood, coatings, electronics, furniture and household products.
Treated articles generally do not require biocidal product authorisation in the same way as biocidal products, but companies should verify:
whether the active substance used in the treatment meets the applicable BPR conditions;
whether Article 58 labelling requirements apply;
whether antimicrobial, anti-mould, preservative or similar claims are adequately substantiated;
whether the supplier can provide information on the biocidal treatment to consumers within the regulatory timeframe; and
whether the product has a primary biocidal function. If it does, it may be considered a biocidal product and product authorisation requirements should be reassessed.
How Does an EU BPR Project Typically Proceed?
Data requirements vary significantly between projects, but a typical EU BPR compliance project can be structured as follows:
Scope and PT Assessment
Confirm the product status, intended use, claims, active substance and target markets.
Active Substance and Supply-Chain Check
Confirm approval/Review Programme status, Article 95 position and data-access situation.
Compliance Route and Data-Gap Assessment
Determine whether product authorisation, technical equivalence, national transitional requirements or treated article compliance applies, and identify any missing data or testing needs.
Testing, Risk Assessment and Dossier Preparation
Arrange or review the required efficacy, physicochemical, toxicology, ecotoxicology and other studies, and prepare the technical dossier and risk assessments as required.
Submission and Post-Submission Support
Prepare applications through IUCLID/R4BP 3 where applicable, respond to authority questions, and support variations, renewals and ongoing compliance.
How Long Does EU BPR Compliance Take, and What Determines the Cost?
There is no single EU BPR timeline or fixed project cost that applies to every company. The overall schedule and budget depend on the compliance route, active substance status, data gaps and data access, testing or technical equivalence needs, the number of target Member States, and the complexity of the product portfolio or SKUs.
Before commissioning extensive testing or purchasing data, companies should first complete a regulatory route and data-gap assessment. This helps reduce the risk of choosing an unsuitable route, duplicating studies or purchasing data that are not needed.
REACH24H EU BPR Compliance Services
BPR Scope & Compliance Route Assessment
Product/treated article classification, PT determination, active substance status review, target-market assessment and compliance-gap analysis.
Active Substance, Article 95 & Technical Equivalence
Active substance approval/renewal, data strategy, Article 95 listing, LoA/data access, technical equivalence assessment and application support.
Biocidal Product Authorisation & Member State Market Access
National authorisation, mutual recognition, Union authorisation, simplified authorisation and applicable national transitional registration/notification support.
Treated Article Compliance
Product-status assessment, active substance status checks, labelling and claims review, compliance documentation and consumer-information support.
Testing, Data & Risk Assessment Support
Data-gap analysis, efficacy and other testing coordination, human-health and environmental risk assessment, and dossier preparation.
Post-Authorisation Maintenance & Ongoing Compliance
Variations and renewals, Member State expansion, supply-chain or active-substance source changes, and regulatory monitoring.
Why Choose REACH24H for EU BPR Compliance?
10+ Years
EU BPR and global biocide regulatory experience
1,000+
EU BPR-related projects completed
400+
companies supported across global markets
20+
European companies supported on new active substance approval and biocidal product authorisation projects
Proven Experience in Complex Active Substance Projects
REACH24H was the first Asia-based regulatory service provider to submit an EU BPR new active substance approval application. Its project capabilities cover data-gap analysis, testing strategy, human-health and environmental assessment, risk assessment, dossier preparation and submission support.
REACH24H has supported dozens of non-EU suppliers with Article 95 compliance across active substances such as sodium dichloroisocyanurate, trichloroisocyanuric acid, calcium hypochlorite and ethanol. More than 90% of active substance suppliers from China, including Taiwan Region, have chosen REACH24H for EU BPR compliance support, demonstrating deep experience in helping non-EU supply chains meet EU market-access requirements. In an early milestone project, REACH24H completed an active substance approval submission and helped three Asian companies successfully enter the Article 95 list. Read the success study.
Full-Chain EU BPR Capability
REACH24H supports the full EU BPR compliance chain, including active substance approval, Article 95, technical equivalence, product authorisation, Member State market access, treated article compliance, data/testing strategy and post-authorisation maintenance. This allows companies to coordinate regulatory, testing and dossier work under one project strategy.
EU Regulatory, Laboratory & Consortium Coordination
REACH24H has extensive experience coordinating BPR projects involving ECHA, national competent authorities, GLP laboratories, industry task forces, associations and consortia. This supports efficient regulatory communication, testing coordination, data access, dossier execution and issue resolution throughout complex BPR projects.
Global & Cross-Border Market Access Support
REACH24H supports both non-EU manufacturers entering the European market and EU-based companies managing active substance and product authorisation projects. More than 20 European companies have engaged REACH24H for new active substance approval and biocidal product authorisation work. REACH24H is also part of the Amazon Service Provider Network, supporting cross-border sellers with global regulatory compliance and market access. Learn more about REACH24H on Amazon SPN.
EU BPR Frequently Asked Questions
EU BPR COMPLIANCE SUPPORT
Start Your EU BPR Compliance Assessment
If you plan to place a disinfectant, preservative, insecticide/repellent, active substance, or antimicrobial/anti-mould treated product on the EU market, provide the product use, formulation/active substance, target Member States, supply-chain information and available test data. REACH24H can assess the applicable EU BPR route, key data gaps, project timeline and implementation plan.
Recommended Reading
Lower-Cost EU BPR Compliance: Treated Articles & Simplified Authorisation
EU BPR Radar: Latest Approvals and Non-Approvals for Biocidal Active Substances
REACH24H Assists Three Asian Companies in Achieving EU BPR Active Substance Approval
EU BPR: Active Substance Renewal Deadlines for 2025 and Beyond
Official Resources
